INVESTMENT FIELD

  • 28am31Asia/Shanghai_f2021Sun, 28 Mar 2021 00:00:00 +080003am31_00Sunday0003

    28am31Asia/Shanghai_f2021Sun, 28 Mar 2021 00:00:00 +080003am31_21Asia/ShanghaiamSun, 28 Mar 2021 00:00:00 +0800

    Gene therapy
    to deliver target genes through a variety of innovative vectors to treat diseases caused by defective and abnormal genes, therefore achieving long-term remission or even full recovery.

  • 28am31Asia/Shanghai_f2021Sun, 28 Mar 2021 00:00:00 +080003am31_00Sunday0003

    28am31Asia/Shanghai_f2021Sun, 28 Mar 2021 00:00:00 +080003am31_21Asia/ShanghaiamSun, 28 Mar 2021 00:00:00 +0800

    Cell therapy
    to track the cutting-edge progress of autologous & allogeneic cell therapy for the treatment of tumors, metabolic abnormalities, aging, etc.

  • 28am31Asia/Shanghai_f2021Sun, 28 Mar 2021 00:00:00 +080003am31_00Sunday0003

    28am31Asia/Shanghai_f2021Sun, 28 Mar 2021 00:00:00 +080003am31_21Asia/ShanghaiamSun, 28 Mar 2021 00:00:00 +0800

    New biological entities (NBEs)
    to explore cooperation opportunities with new entities such as bispecific antibodies, ADCs, nucleic acid medicine, etc. and expand horizons in drug discovery & design to create the next blockbuster.